United States Human Immunoglobulin Market Report 2017

October 2017 | 105 pages | ID: UA351EF8DD9EN
QYResearch

Abstracts

In this report, the United States Human Immunoglobulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Human Immunoglobulin in these regions, from 2012 to 2022 (forecast).

United States Human Immunoglobulin market competition by top manufacturers/players, with Human Immunoglobulin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Shire
• CSL
• Grifols
• Octapharma
• Biotest
• China National Pharmaceutical Group Corporation
• CTBB
• Hualan Bio
• RASS
• Shanxi Kangbao Biological Product
• Shuanglin Bio Pharma
• Sichuan Yuanda Shuyang Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Intramuscular Injection
• Intravenous Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Human Immunoglobulin for each application, including

• Disease Prevention
• Treatment
• Diagnosis
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Human Immunoglobulin Market Report 2017

1 HUMAN IMMUNOGLOBULIN OVERVIEW

1.1 Product Overview and Scope of Human Immunoglobulin
1.2 Classification of Human Immunoglobulin by Product Category
  1.2.1 United States Human Immunoglobulin Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Human Immunoglobulin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Intramuscular Injection
  1.2.4 Intravenous Injection
1.3 United States Human Immunoglobulin Market by Application/End Users
  1.3.1 United States Human Immunoglobulin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Disease Prevention
  1.3.3 Treatment
  1.3.4 Diagnosis
  1.3.5 Other
1.4 United States Human Immunoglobulin Market by Region
  1.4.1 United States Human Immunoglobulin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Human Immunoglobulin Status and Prospect (2012-2022)
  1.4.3 Southwest Human Immunoglobulin Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Human Immunoglobulin Status and Prospect (2012-2022)
  1.4.5 New England Human Immunoglobulin Status and Prospect (2012-2022)
  1.4.6 The South Human Immunoglobulin Status and Prospect (2012-2022)
  1.4.7 The Midwest Human Immunoglobulin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Immunoglobulin (2012-2022)
  1.5.1 United States Human Immunoglobulin Sales and Growth Rate (2012-2022)
  1.5.2 United States Human Immunoglobulin Revenue and Growth Rate (2012-2022)

2 UNITED STATES HUMAN IMMUNOGLOBULIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Immunoglobulin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Immunoglobulin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Immunoglobulin Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Immunoglobulin Market Competitive Situation and Trends
  2.4.1 United States Human Immunoglobulin Market Concentration Rate
  2.4.2 United States Human Immunoglobulin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Immunoglobulin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN IMMUNOGLOBULIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Human Immunoglobulin Sales and Market Share by Region (2012-2017)
3.2 United States Human Immunoglobulin Revenue and Market Share by Region (2012-2017)
3.3 United States Human Immunoglobulin Price by Region (2012-2017)

4 UNITED STATES HUMAN IMMUNOGLOBULIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Human Immunoglobulin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Immunoglobulin Revenue and Market Share by Type (2012-2017)
4.3 United States Human Immunoglobulin Price by Type (2012-2017)
4.4 United States Human Immunoglobulin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HUMAN IMMUNOGLOBULIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Human Immunoglobulin Sales and Market Share by Application (2012-2017)
5.2 United States Human Immunoglobulin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN IMMUNOGLOBULIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Shire
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Immunoglobulin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Shire Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 CSL
  6.2.2 Human Immunoglobulin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 CSL Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Grifols
  6.3.2 Human Immunoglobulin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Grifols Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Octapharma
  6.4.2 Human Immunoglobulin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Octapharma Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biotest
  6.5.2 Human Immunoglobulin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biotest Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 China National Pharmaceutical Group Corporation
  6.6.2 Human Immunoglobulin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 China National Pharmaceutical Group Corporation Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 CTBB
  6.7.2 Human Immunoglobulin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 CTBB Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Hualan Bio
  6.8.2 Human Immunoglobulin Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Hualan Bio Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 RASS
  6.9.2 Human Immunoglobulin Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 RASS Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Shanxi Kangbao Biological Product
  6.10.2 Human Immunoglobulin Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Shanxi Kangbao Biological Product Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Shuanglin Bio Pharma
6.12 Sichuan Yuanda Shuyang Pharmaceutical

7 HUMAN IMMUNOGLOBULIN MANUFACTURING COST ANALYSIS

7.1 Human Immunoglobulin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Immunoglobulin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Immunoglobulin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Immunoglobulin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN IMMUNOGLOBULIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Human Immunoglobulin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Immunoglobulin Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Immunoglobulin Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Immunoglobulin Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Immunoglobulin
Figure United States Human Immunoglobulin Market Size (K Doses) by Type (2012-2022)
Figure United States Human Immunoglobulin Sales Volume Market Share by Type (Product Category) in 2016
Figure Intramuscular Injection Product Picture
Figure Intravenous Injection Product Picture
Figure United States Human Immunoglobulin Market Size (K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Human Immunoglobulin by Application in 2016
Figure Disease Prevention Examples
Table Key Downstream Customer in Disease Prevention
Figure Treatment Examples
Table Key Downstream Customer in Treatment
Figure Diagnosis Examples
Table Key Downstream Customer in Diagnosis
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Human Immunoglobulin Market Size (Million USD) by Region (2012-2022)
Figure The West Human Immunoglobulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Immunoglobulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Immunoglobulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Immunoglobulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Immunoglobulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Immunoglobulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Immunoglobulin Sales (K Doses) and Growth Rate (2012-2022)
Figure United States Human Immunoglobulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Immunoglobulin Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table United States Human Immunoglobulin Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table United States Human Immunoglobulin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Immunoglobulin Sales Share by Players/Suppliers
Figure 2017 United States Human Immunoglobulin Sales Share by Players/Suppliers
Figure United States Human Immunoglobulin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Immunoglobulin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Immunoglobulin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Immunoglobulin Revenue Share by Players/Suppliers
Figure 2017 United States Human Immunoglobulin Revenue Share by Players/Suppliers
Table United States Market Human Immunoglobulin Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Human Immunoglobulin Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Human Immunoglobulin Market Share of Top 3 Players/Suppliers
Figure United States Human Immunoglobulin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Immunoglobulin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Immunoglobulin Product Category
Table United States Human Immunoglobulin Sales (K Doses) by Region (2012-2017)
Table United States Human Immunoglobulin Sales Share by Region (2012-2017)
Figure United States Human Immunoglobulin Sales Share by Region (2012-2017)
Figure United States Human Immunoglobulin Sales Market Share by Region in 2016
Table United States Human Immunoglobulin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Immunoglobulin Revenue Share by Region (2012-2017)
Figure United States Human Immunoglobulin Revenue Market Share by Region (2012-2017)
Figure United States Human Immunoglobulin Revenue Market Share by Region in 2016
Table United States Human Immunoglobulin Price (USD/Dose) by Region (2012-2017)
Table United States Human Immunoglobulin Sales (K Doses) by Type (2012-2017)
Table United States Human Immunoglobulin Sales Share by Type (2012-2017)
Figure United States Human Immunoglobulin Sales Share by Type (2012-2017)
Figure United States Human Immunoglobulin Sales Market Share by Type in 2016
Table United States Human Immunoglobulin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Immunoglobulin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Immunoglobulin by Type (2012-2017)
Figure Revenue Market Share of Human Immunoglobulin by Type in 2016
Table United States Human Immunoglobulin Price (USD/Dose) by Types (2012-2017)
Figure United States Human Immunoglobulin Sales Growth Rate by Type (2012-2017)
Table United States Human Immunoglobulin Sales (K Doses) by Application (2012-2017)
Table United States Human Immunoglobulin Sales Market Share by Application (2012-2017)
Figure United States Human Immunoglobulin Sales Market Share by Application (2012-2017)
Figure United States Human Immunoglobulin Sales Market Share by Application in 2016
Table United States Human Immunoglobulin Sales Growth Rate by Application (2012-2017)
Figure United States Human Immunoglobulin Sales Growth Rate by Application (2012-2017)
Table Shire Basic Information List
Table Shire Human Immunoglobulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Shire Human Immunoglobulin Sales Growth Rate (2012-2017)
Figure Shire Human Immunoglobulin Sales Market Share in United States (2012-2017)
Figure Shire Human Immunoglobulin Revenue Market Share in United States (2012-2017)
Table CSL Basic Information List
Table CSL Human Immunoglobulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure CSL Human Immunoglobulin Sales Growth Rate (2012-2017)
Figure CSL Human Immunoglobulin Sales Market Share in United States (2012-2017)
Figure CSL Human Immunoglobulin Revenue Market Share in United States (2012-2017)
Table Grifols Basic Information List
Table Grifols Human Immunoglobulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Grifols Human Immunoglobulin Sales Growth Rate (2012-2017)
Figure Grifols Human Immunoglobulin Sales Market Share in United States (2012-2017)
Figure Grifols Human Immunoglobulin Revenue Market Share in United States (2012-2017)
Table Octapharma Basic Information List
Table Octapharma Human Immunoglobulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Octapharma Human Immunoglobulin Sales Growth Rate (2012-2017)
Figure Octapharma Human Immunoglobulin Sales Market Share in United States (2012-2017)
Figure Octapharma Human Immunoglobulin Revenue Market Share in United States (2012-2017)
Table Biotest Basic Information List
Table Biotest Human Immunoglobulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Biotest Human Immunoglobulin Sales Growth Rate (2012-2017)
Figure Biotest Human Immunoglobulin Sales Market Share in United States (2012-2017)
Figure Biotest Human Immunoglobulin Revenue Market Share in United States (2012-2017)
Table China National Pharmaceutical Group Corporation Basic Information List
Table China National Pharmaceutical Group Corporation Human Immunoglobulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure China National Pharmaceutical Group Corporation Human Immunoglobulin Sales Growth Rate (2012-2017)
Figure China National Pharmaceutical Group Corporation Human Immunoglobulin Sales Market Share in United States (2012-2017)
Figure China National Pharmaceutical Group Corporation Human Immunoglobulin Revenue Market Share in United States (2012-2017)
Table CTBB Basic Information List
Table CTBB Human Immunoglobulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure CTBB Human Immunoglobulin Sales Growth Rate (2012-2017)
Figure CTBB Human Immunoglobulin Sales Market Share in United States (2012-2017)
Figure CTBB Human Immunoglobulin Revenue Market Share in United States (2012-2017)
Table Hualan Bio Basic Information List
Table Hualan Bio Human Immunoglobulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Hualan Bio Human Immunoglobulin Sales Growth Rate (2012-2017)
Figure Hualan Bio Human Immunoglobulin Sales Market Share in United States (2012-2017)
Figure Hualan Bio Human Immunoglobulin Revenue Market Share in United States (2012-2017)
Table RASS Basic Information List
Table RASS Human Immunoglobulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure RASS Human Immunoglobulin Sales Growth Rate (2012-2017)
Figure RASS Human Immunoglobulin Sales Market Share in United States (2012-2017)
Figure RASS Human Immunoglobulin Revenue Market Share in United States (2012-2017)
Table Shanxi Kangbao Biological Product Basic Information List
Table Shanxi Kangbao Biological Product Human Immunoglobulin Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Shanxi Kangbao Biological Product Human Immunoglobulin Sales Growth Rate (2012-2017)
Figure Shanxi Kangbao Biological Product Human Immunoglobulin Sales Market Share in United States (2012-2017)
Figure Shanxi Kangbao Biological Product Human Immunoglobulin Revenue Market Share in United States (2012-2017)
Table Shuanglin Bio Pharma Basic Information List
Table Sichuan Yuanda Shuyang Pharmaceutical Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Immunoglobulin
Figure Manufacturing Process Analysis of Human Immunoglobulin
Figure Human Immunoglobulin Industrial Chain Analysis
Table Raw Materials Sources of Human Immunoglobulin Major Players/Suppliers in 2016
Table Major Buyers of Human Immunoglobulin
Table Distributors/Traders List
Figure United States Human Immunoglobulin Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Human Immunoglobulin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Immunoglobulin Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Human Immunoglobulin Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Human Immunoglobulin Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Human Immunoglobulin Sales Volume (K Doses) Forecast by Type in 2022
Table United States Human Immunoglobulin Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Human Immunoglobulin Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Human Immunoglobulin Sales Volume (K Doses) Forecast by Application in 2022
Table United States Human Immunoglobulin Sales Volume (K Doses) Forecast by Region (2017-2022)
Table United States Human Immunoglobulin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Immunoglobulin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Immunoglobulin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources